@article{b9424c25d45f43c0ad51482e77f405af,
title = "Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection",
author = "Hiroyuki Kunishima and Hiroki Ohge and Hiromichi Suzuki and Atsushi Nakamura and Kazuaki Matsumoto and Hiroshige Mikamo and Nobuaki Mori and Yoshitomo Morinaga and Katsunori Yanagihara and Yuka Yamagishi and Sadako Yoshizawa",
note = "Funding Information: Formulation of the present guidelines was entirely funded by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Funding Information: Yuka Yamagishi received scholarship funds from MSD K.K., Asahi Kasei Pharma Corp., Astellas Pharma Inc., Eneforest Co., Ltd., Shionogi & Co., Ltd., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Toyama Chemical Co., Ltd., Pfizer Japan Inc., FUJIFILM Pharma Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., and Meiji Seika Pharma Co., Ltd.",
year = "2022",
month = aug,
doi = "10.1016/j.jiac.2021.12.011",
language = "English",
volume = "28",
pages = "1045--1083",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "8",
}
